Close Menu
    What's Hot

    Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

    April 22, 2026

    Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

    April 22, 2026

    As PRT Market Grows, Service Providers Look for Ways to Keep Up

    April 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      US Individual Life Insurance New Premium To Set New Sales Record in 2025

      March 4, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      As PRT Market Grows, Service Providers Look for Ways to Keep Up

      April 22, 2026

      Q&A: Daniel Taylor, Client Director, Trafalgar House

      April 22, 2026

      Videndum DB Pension Scheme To Transfer Members and Assets to Clara

      April 21, 2026
      Milliman

      US Pension Risk Transfer Cost Increases in March

      April 20, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

      April 9, 2026

      Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

      April 9, 2026

      Is the Secondary Life Insurance Market in the UK Set To Re-Emerge?

      April 9, 2026

      Q&A: Brandon Marz, Co-Founder and Chief Strategy Officer, LifeRoc Capital

      March 25, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      As PRT Market Grows, Service Providers Look for Ways to Keep Up

      April 22, 2026

      Q&A: Daniel Taylor, Client Director, Trafalgar House

      April 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Carl Groth, Chief Risk Officer, Legal and General Retirement America

    Longevity and Mortality Risk Transfer August 13, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    Total US pension risk transfer (PRT) new premium was $7.1bn in the first quarter of 2025, according to LIMRA’s U.S. Group Annuity Risk Transfer Sales Survey. While this is 51% lower than the record-high sales set in the first quarter of 2024, at 127 contracts, the market contracted only 13% from prior year. Greg Winterton caught up with Carl Groth, Chief Risk Officer at Legal & General Retirement America, to get his thoughts on the state of the market as we enter H2. 

    GW: Carl, pension risk transfer activity in the US so far this year is down when compared to 2024. What have been the main drivers of the pullback? 

    CG: One driver is a reduction in the jumbo (multi-billion) deals throughout the first half of the year. These big deals can drive up market volumes considerably and reduce volumes when they do not go to market. We saw fewer jumbo deals in the first half of this year compared to last year. However, the market for non-jumbo deals looks to be picking up as we are starting the second half of 2025. 

    GW: How do you assess and manage the long-term liabilities associated with pension risk transfer deals, especially in an interest rate and mortality environment that is arguably unclear at present? 

    CG: I will address mortality first. We devote considerable resources to the science of mortality. For example, we study the uptake and impact of new drugs, such as semaglutides and trends in various forms of disease across demographic groups. This effort helps us calibrate longevity trend factors used in our pricing. Additionally, we use a multifactor model to predict longevity and update the model regularly. The size of our PRT back book is considerable and enables us to back test actual results against pricing assumptions and make any necessary adjustments.  

    Management of interest rates is primarily done through ALM – matching asset duration or cash flows to the liability asset duration or cash flow depending on the size of the business and the regulatory requirements. We run sensitivities and stresses to get comfortable with the ability to stay reasonably matched. 

    GW: What trends are you observing in plan sponsor behaviour, and how are those trends shaping insurer appetite or approach to PRT transactions? 

    CG: In general, plan sponsors remain keen to derisk. The derisking process often takes several years and as such, can be temporarily interrupted by more pressing business issues. An example of a pressing business issue that is affecting some plan sponsors this year is assessing the potential impact of tariffs on their business. This issue can take time away from the same individuals that might be involved with taking a case to market (e.g. the Finance function). 

    GW: What are the key operational and counterparty risks in executing and managing large PRT deals, and how do you oversee them at the enterprise level? 

    CG: For insurers that also provide the administration for their annuitants, that implicitly involves operational risk throughout the life of a deal. Other operational risks might include model or human errors in pricing, information security risk, and risks inherent in the investment management process. In our case, counterparty risks in the traditional sense, are limited to a relatively small amount of reinsurance and or partnering on deals.  

    These risks are overseen at various levels, beginning with the first line of defence that provides a solid foundation for risk oversight. Each entity and major business within each entity should also have its own risk committee, with risk committees at the group level as well. 

    GW: Lastly, Carl, how do you see the US PRT market evolving over the next three to five years, and what are the main strategic or systemic risks you think the industry should be preparing for? 

    CG: I see the US PRT market continuing to flourish over this time horizon and expect market volumes to be driven by the presence or absence of the multi-billion dollar deals as mentioned earlier. One area that I would highlight is the growing number of competitors in the space. There are currently over 20 insurers active in the PRT market and high demand from plan sponsors. While this increased activity brings innovation and choices to plan sponsors, it also means careful attention must be paid to pricing discipline and risk management. Ultimately, I believe market dynamics and responsible management will foster continued growth. 

    Carl Groth is Chief Risk Officer at Legal and General Retirement America 

    2025 - August Longevity Risk Pension Risk Transfer Q&A Volume 4 Issue 8 – August 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

    April 22, 2026By Greg Winterton

    Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

    April 22, 2026By Greg Winterton

    As PRT Market Grows, Service Providers Look for Ways to Keep Up

    April 22, 2026By Mark McCord

    Q&A: Daniel Taylor, Client Director, Trafalgar House

    April 22, 2026By Greg Winterton
    Latest Issue

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026

    Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

    April 9, 2026

    Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

    April 9, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.